Purdue opioid settlement talks stall ahead of federal trial
Negotiations aimed at a nationwide settlement with Purdue Pharma over the opioid crisis are at a standstill six weeks before the first federal trial. Talks involve state attorneys general, local governments, and the Sackler family, with a proposed structure including a $10 billion to $12 billion plan and $3 billion from the Sacklers, but agreement remains elusive.